الإحصائيات الأساسية
| LEI | 549300NNUTG7HCZICS76 |
| CIK | 742112 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Invacare Corp.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| October 31, 2024 |
SC 13D/A 1 p24-3126sc13da.htm INVACARE HOLDINGS CORP SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* Invacare Holdings Corporation (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Shulamit Leviant, Esq. c/o Davidson Kempner Capital Management LP 520 |
|
| October 30, 2024 |
US461203AH42 / Invacare Corp Bond / DG Capital Management, LLC - SC 13D/A Activist Investment SC 13D/A 1 d860797dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Dov Gertzulin DG Capital Management, LLC 460 Park Avenue, 22nd Floor Ne |
|
| October 30, 2024 |
AMENDED AND RESTATED EXCHANGE AGREEMENT EX-99.7 3 d860797dex997.htm EX-99.7 Exhibit 7 AMENDED AND RESTATED EXCHANGE AGREEMENT This Amended and Restated Exchange Agreement (this “Agreement”) is made and entered as of October 29, 2024 by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“International Holdings”), Invacare Corporation, an Ohio corporat |
|
| October 30, 2024 |
EX-99.9 5 d860797dex999.htm EX-99.9 Exhibit 9 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF 9.00% SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK OF INVACARE HOLDINGS CORPORATION Invacare Holdings Corporation, a corporation organized under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: I. The Board of Directors of the Corporation, by resolutions ado |
|
| October 30, 2024 |
FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS EX-99.12 8 d861834dex9912.htm EX-99.12 Exhibit 12 FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS This FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS (together with the schedules and Exhibits A and B hereto, this “Agreement”) is entered into as of October 29, 2024, by and among the following parties hereto (excludin |
|
| October 30, 2024 |
SC 13D/A 1 d884805dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Robin Shah Tenor Capital Management Company, L.P. 810 Seventh Avenue, S |
|
| October 30, 2024 |
EX-99.7 6 d877627dex997.htm EX-99.7 Exhibit 7 INVACARE HOLDINGS CORPORATION CERTIFICATE OF DESIGNATIONS Pursuant to Section 151 of the General Corporation Law of the State of Delaware SERIES B REDEEMABLE PREFERRED STOCK (Par Value $0.001 Per Share) Invacare Holdings Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporatio |
|
| October 30, 2024 |
MASTER EQUITY AGREEMENT TERMINATION AGREEMENT EX-99.8 4 d861834dex998.htm EX-99.8 Exhibit 8 MASTER EQUITY AGREEMENT TERMINATION AGREEMENT This Termination Agreement (this “Agreement”), dated as of October 29, 2024, is entered into by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“International Holdings”), Invacare Corporation, an Ohio corporation (“Re |
|
| October 30, 2024 |
FORM OF FIRST AMENDMENT BOARD OBSERVER AGREEMENT EX-99.11 7 d861834dex9911.htm EX-99.11 Exhibit 11 FORM OF FIRST AMENDMENT TO BOARD OBSERVER AGREEMENT This Amendment to Board Observer Agreement (this “Amendment”) is made as of October 29, 2024, by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and (the “Investor”). WHEREAS, the Company and Investor are parties to that certain board observer agreement, effectiv |
|
| October 30, 2024 |
FORM OF FIRST AMENDMENT BOARD OBSERVER AGREEMENT EX-99.11 7 d884805dex9911.htm EX-99.11 Exhibit 11 FORM OF FIRST AMENDMENT TO BOARD OBSERVER AGREEMENT This Amendment to Board Observer Agreement (this “Amendment”) is made as of October 29, 2024, by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and (the “Investor”). WHEREAS, the Company and Investor are parties to that certain board observer agreement, effectiv |
|
| October 30, 2024 |
AMENDED AND RESTATED EXCHANGE AGREEMENT EX-99.7 3 d884805dex997.htm EX-99.7 Exhibit 7 AMENDED AND RESTATED EXCHANGE AGREEMENT This Amended and Restated Exchange Agreement (this “Agreement”) is made and entered as of October 29, 2024 by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“International Holdings”), Invacare Corporation, an Ohio corporat |
|
| October 30, 2024 |
FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS EX-99.12 8 d860797dex9912.htm EX-99.12 Exhibit 12 FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS This FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS (together with the schedules and Exhibits A and B hereto, this “Agreement”) is entered into as of October 29, 2024, by and among the following parties hereto (excludin |
|
| October 30, 2024 |
MASTER EQUITY AGREEMENT TERMINATION AGREEMENT EX-99.8 4 d860797dex998.htm EX-99.8 Exhibit 8 MASTER EQUITY AGREEMENT TERMINATION AGREEMENT This Termination Agreement (this “Agreement”), dated as of October 29, 2024, is entered into by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“International Holdings”), Invacare Corporation, an Ohio corporation (“Re |
|
| October 30, 2024 |
FORM OF FIRST AMENDMENT BOARD OBSERVER AGREEMENT EX-99.8 7 d877627dex998.htm EX-99.8 EXHIBIT 8 FORM OF FIRST AMENDMENT TO BOARD OBSERVER AGREEMENT This Amendment to Board Observer Agreement (this “Amendment”) is made as of October 29, 2024, by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and (the “Investor”). WHEREAS, the Company and Investor are parties to that certain board observer agreement, effective as |
|
| October 30, 2024 |
MASTER EQUITY AGREEMENT TERMINATION AGREEMENT EX-99.8 4 d884805dex998.htm EX-99.8 Exhibit 8 MASTER EQUITY AGREEMENT TERMINATION AGREEMENT This Termination Agreement (this “Agreement”), dated as of October 29, 2024, is entered into by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“International Holdings”), Invacare Corporation, an Ohio corporation (“Re |
|
| October 30, 2024 |
FORM OF FIRST AMENDMENT BOARD OBSERVER AGREEMENT EX-99.11 7 d860797dex9911.htm EX-99.11 EXHIBIT 11 FORM OF FIRST AMENDMENT TO BOARD OBSERVER AGREEMENT This Amendment to Board Observer Agreement (this “Amendment”) is made as of October 29, 2024, by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and (the “Investor”). WHEREAS, the Company and Investor are parties to that certain board observer agreement, effectiv |
|
| October 30, 2024 |
FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-99.6 2 d860797dex996.htm EX-99.6 Exhibit 6 FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of October 29, 2024, is entered into by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“Parent”), INVACARE CORPORATION, an Ohio corporation (“Invacare”), |
|
| October 30, 2024 |
EX-99.10 6 d860797dex9910.htm EX-99.10 Exhibit 10 INVACARE HOLDINGS CORPORATION CERTIFICATE OF DESIGNATIONS Pursuant to Section 151 of the General Corporation Law of the State of Delaware SERIES B REDEEMABLE PREFERRED STOCK (Par Value $0.001 Per Share) Invacare Holdings Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corpor |
|
| October 30, 2024 |
AMENDED AND RESTATED EXCHANGE AGREEMENT EX-99.7 3 d861834dex997.htm EX-99.7 Exhibit 7 AMENDED AND RESTATED EXCHANGE AGREEMENT This Amended and Restated Exchange Agreement (this “Agreement”) is made and entered as of October 29, 2024 by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“International Holdings”), Invacare Corporation, an Ohio corporat |
|
| October 30, 2024 |
MASTER EQUITY AGREEMENT TERMINATION AGREEMENT EX-99.5 4 d877627dex995.htm EX-99.5 Exhibit 5 MASTER EQUITY AGREEMENT TERMINATION AGREEMENT This Termination Agreement (this “Agreement”), dated as of October 29, 2024, is entered into by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“International Holdings”), Invacare Corporation, an Ohio corporation (“Re |
|
| October 30, 2024 |
FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS EX-99.12 8 d884805dex9912.htm EX-99.12 Exhibit 12 FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS This FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS (together with the schedules and Exhibits A and B hereto, this “Agreement”) is entered into as of October 29, 2024, by and among the following parties hereto (excludin |
|
| October 30, 2024 |
US461203AH42 / Invacare Corp Bond / SILVERBACK ASSET MANAGEMENT LLC - SC 13D/A Activist Investment SC 13D/A 1 d861834dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Elliot Bossen Silverback Asset Management, LLC 1414 Raleigh Road Chapel |
|
| October 30, 2024 |
EX-99.9 5 d861834dex999.htm EX-99.9 Exhibit 9 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF 9.00% SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK OF INVACARE HOLDINGS CORPORATION Invacare Holdings Corporation, a corporation organized under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: I. The Board of Directors of the Corporation, by resolutions ado |
|
| October 30, 2024 |
FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-99.6 2 d884805dex996.htm EX-99.6 Exhibit 6 FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of October 29, 2024, is entered into by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“Parent”), INVACARE CORPORATION, an Ohio corporation (“Invacare”), |
|
| October 30, 2024 |
US461203AH42 / Invacare Corp Bond / Endurant Capital Management LP - SC 13D/A Activist Investment SC 13D/A 1 d877627dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Quang Minh Pham Endurant Capital Management, LP 66 Bovet Road, Suite 35 |
|
| October 30, 2024 |
FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS EX-99.9 8 d877627dex999.htm EX-99.9 Exhibit 9 FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS This FORBEARANCE AGREEMENT AND FIRST OMNIBUS AMENDMENT TO CREDIT AGREEMENT AND LOAN DOCUMENTS (together with the schedules and Exhibits A and B hereto, this “Agreement”) is entered into as of October 29, 2024, by and among the following parties hereto (excluding th |
|
| October 30, 2024 |
AMENDED AND RESTATED EXCHANGE AGREEMENT EX-99.4 3 d877627dex994.htm EX-99.4 Exhibit 4 AMENDED AND RESTATED EXCHANGE AGREEMENT This Amended and Restated Exchange Agreement (this “Agreement”) is made and entered as of October 29, 2024 by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“International Holdings”), Invacare Corporation, an Ohio corporat |
|
| October 30, 2024 |
EX-99.6 5 d877627dex996.htm EX-99.6 Exhibit 6 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF 9.00% SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK OF INVACARE HOLDINGS CORPORATION Invacare Holdings Corporation, a corporation organized under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: I. The Board of Directors of the Corporation, by resolutions ado |
|
| October 30, 2024 |
FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-99.3 2 d877627dex993.htm EX-99.3 Exhibit 3 FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of October 29, 2024, is entered into by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“Parent”), INVACARE CORPORATION, an Ohio corporation (“Invacare”), |
|
| October 30, 2024 |
EX-99.10 6 d884805dex9910.htm EX-99.10 Exhibit 10 INVACARE HOLDINGS CORPORATION CERTIFICATE OF DESIGNATIONS Pursuant to Section 151 of the General Corporation Law of the State of Delaware SERIES B REDEEMABLE PREFERRED STOCK (Par Value $0.001 Per Share) Invacare Holdings Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corpor |
|
| October 30, 2024 |
EX-99.9 5 d884805dex999.htm EX-99.9 Exhibit 9 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS OF 9.00% SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK OF INVACARE HOLDINGS CORPORATION Invacare Holdings Corporation, a corporation organized under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: I. The Board of Directors of the Corporation, by resolutions ado |
|
| October 30, 2024 |
FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT EX-99.6 2 d861834dex996.htm EX-99.6 Exhibit 6 FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT This FORBEARANCE AGREEMENT AND FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of October 29, 2024, is entered into by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“Parent”), INVACARE CORPORATION, an Ohio corporation (“Invacare”), |
|
| October 30, 2024 |
EX-99.10 6 d861834dex9910.htm EX-99.10 Exhibit 10 INVACARE HOLDINGS CORPORATION CERTIFICATE OF DESIGNATIONS Pursuant to Section 151 of the General Corporation Law of the State of Delaware SERIES B REDEEMABLE PREFERRED STOCK (Par Value $0.001 Per Share) Invacare Holdings Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corpor |
|
| August 22, 2024 |
US461203AH42 / Invacare Corp Bond / Rosen Steven H - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) N/A (CUSIP Number) Steven H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 350 Cleveland, OH 44122 (216) 292-453 |
|
| August 22, 2024 |
EX-99.7 2 d875259dex997.htm EX-99.7 Exhibit 7 [***] INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Azurite Management, LLC 25101 Chagrin Blvd. Suite 330 Cleveland, OH 44122 Augus |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-15103 INVACARE HOLDINGS CORPORATION (Exact name of registrant as specif |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-15103 INVACARE HOLDINGS CORPORATION (Exact name of registrant as specif |
|
| August 8, 2024 |
As filed with the Securities and Exchange Commission on August 8, 2024 As filed with the Securities and Exchange Commission on August 8, 2024 Registration No. |
|
| May 31, 2024 |
Invacare Holdings Corporation Conflict Minerals Report For The Year Ended December 31, 2023 Exhibit 1.01 Invacare Holdings Corporation Conflict Minerals Report For The Year Ended December 31, 2023 This report for the year ended December 31, 2023 is provided pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended (the “Rule”). This report has been prepared by Invacare Holdings Corporation (herein referred to as “Invacare,” the “Company,” “we,” “us,” or “ou |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INVACARE HOLDINGS CORPORATION (Exact name of Registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Invacare Way, Elyria, Ohio 44035 (Address of principal exec |
|
| May 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on F |
|
| May 9, 2024 |
US461203AH42 / Invacare Corp Bond / Rosen Steven H - SC 13D/A Activist Investment SC 13D/A 1 d826323dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Steven H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 3 |
|
| May 9, 2024 |
EX-99.6 2 d826323dex996.htm EX-99.6 Exhibit 6 [***] INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Azurite Management, LLC 25101 Chagrin Blvd. Suite 330 Cleveland, OH 44122 216-2 |
|
| April 11, 2024 |
US461203AH42 / Invacare Corp Bond / SILVERBACK ASSET MANAGEMENT LLC - SC 13D/A Activist Investment SC 13D/A 1 d726893dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Elliot Bossen Silverback Asset Management, LLC 1414 Raleigh Road Chapel |
|
| April 10, 2024 |
US461203AH42 / Invacare Corp Bond / DG Capital Management, LLC - SC 13D/A Activist Investment SC 13D/A 1 d726885dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Dov Gertzulin DG Capital Management, LLC 460 Park Avenue, 22nd Floor Ne |
|
| April 10, 2024 |
SC 13D/A 1 d726912dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Robin Shah Tenor Capital Management Company, L.P. 810 Seventh Avenue, S |
|
| April 10, 2024 |
Exhibit 3.1 INVACARE HOLDINGS CORPORATION SECOND AMENDMENT TO THE CERTIFICATE OF DESIGNATIONS OF 9.00% SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK Invacare Holdings Corporation, a corporation organized under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: I.The Board of Directors of the Corporation (the “Board of Directors”), by resolutions adopted on |
|
| April 10, 2024 |
Exhibit 10.3 EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) is made and entered as of April 8, 2024 (the “Execution Date”) by and among Invacare Holdings Corporation, a Delaware corporation (“Parent”), Invacare International Holdings Corp., a Delaware corporation (“Intermediate Holdings”), Invacare Corporation, an Ohio corporation (“Reorganized Invacare”), and the parties listed on |
|
| April 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2024 (April 4, 2024) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of incor |
|
| April 10, 2024 |
US461203AH42 / Invacare Corp Bond / Endurant Capital Management LP - SC 13D/A Activist Investment SC 13D/A 1 d726891dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Quang Minh Pham Endurant Capital Management, LP 66 Bovet Road, Suite 35 |
|
| April 10, 2024 |
Exhibit 10.2 MASTER EQUITY AGREEMENT This Master Equity Agreement (the “Agreement”) is entered into as of April 8, 2024 (the “Agreement Date”), by and among Invacare Holdings Corporation, a Delaware corporation (the “Parent”), Invacare International Holdings Corp., a Delaware corporation (“Intermediate Holdings”), Invacare Corporation, an Ohio corporation (“Reorganized Invacare”) and each Holder p |
|
| April 10, 2024 |
SC 13D/A 1 p24-1408sc13da.htm INVACARE HOLDINGS CORPORATION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* Invacare Holdings Corporation (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Shulamit Leviant, Esq. c/o Davidson Kempner Capital Management |
|
| April 10, 2024 |
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT Exhibit 10.1 THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT This THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of April 8, 2024, is entered into by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“Parent”), INVACARE CORPORATION, an Ohio corporation (“Invacare”), FREEDOM DESIGNS, INC., a California corporation (“Freedom Designs”), MEDBLOC, INC., a Dela |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2024 (April 3, 2024) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of incorp |
|
| April 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o |
|
| March 15, 2024 |
SC 13D/A 1 d760478dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Robin Shah Tenor Capital Management Company, L.P. 810 Seventh Avenue, S |
|
| March 15, 2024 |
SC 13D/A 1 p24-1224sc13da.htm INVACARE HOLDINGS CORPORATION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Invacare Holdings Corporation (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Shulamit Leviant, Esq. c/o Davidson Kempner Capital Management |
|
| March 15, 2024 |
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT Exhibit 10.1 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT This SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of March 13, 2024, is entered into by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“Parent”), INVACARE CORPORATION, an Ohio corporation (“Invacare”), FREEDOM DESIGNS, INC., a California corporation (“Freedom Designs”), MEDBLOC, INC., a D |
|
| March 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2024 (March 13, 2024) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of inco |
|
| March 15, 2024 |
Exhibit 3.1 INVACARE HOLDINGS CORPORATION FIRST AMENDMENT TO THE CERTIFICATE OF DESIGNATIONS OF 9.00% SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK Invacare Holdings Corporation, a corporation organized under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: I. The Board of Directors of the Corporation (the “Board of Directors”), by resolutions adopted on |
|
| March 15, 2024 |
US461203AH42 / Invacare Corp Bond / SILVERBACK ASSET MANAGEMENT LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Elliot Bossen Silverback Asset Management, LLC 1414 Raleigh Road Chapel Hill, NC 27517 (919) 969-9300 |
|
| March 15, 2024 |
US461203AH42 / Invacare Corp Bond / DG Capital Management, LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Dov Gertzulin DG Capital Management, LLC 460 Park Avenue, 22nd Floor New York, NY 10022 (646) 942-570 |
|
| March 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2024 (March 4, 2024) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of incorp |
|
| March 6, 2024 |
EX-99.5 2 d808384dex995.htm EX-99.5 Exhibit 5 [***] INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Azurite Management, LLC 25101 Chagrin Blvd. Suite 330 Cleveland, OH 44122 216-2 |
|
| March 6, 2024 |
US461203AH42 / Invacare Corp Bond / Rosen Steven H - SC 13D/A Activist Investment SC 13D/A 1 d808384dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Steven H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 3 |
|
| March 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2024 (February 26, 2024) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of in |
|
| March 1, 2024 |
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT Exhibit 10.1 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT This FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of February 26, 2024, is entered into by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“Parent”), INVACARE CORPORATION, an Ohio corporation (“Invacare”), FREEDOM DESIGNS, INC., a California corporation (“Freedom Designs”), MEDBLOC, INC., a |
|
| February 16, 2024 |
Exhibit 3.1 Bylaw Amendments Pursuant to the Action by Majority Written Consent of the Stockholders of Invacare Holdings Corporation (the “Company”), dated February 13, 2024, the following amendments to the Company’s Amended and Restated Bylaws (the “Bylaws”) were approved effective as of February 13, 2024: Section 3.7 of the Bylaws was deleted in its entirety and replaced with the following: “Sec |
|
| February 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2024 (February 13, 2024) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction o |
|
| February 15, 2024 |
US461203AH42 / Invacare Corp Bond / DG Capital Management, LLC - SC 13D/A Activist Investment SC 13D/A 1 d761657dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Dov Gertzulin DG Capital Management, LLC 460 Park Avenue, 22nd Floor Ne |
|
| February 15, 2024 |
SC 13D/A 1 d761521dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Robin Shah Tenor Capital Management Company, L.P. 810 Seventh Avenue, S |
|
| February 15, 2024 |
SC 13D/A 1 p24-0892sc13da.htm INVACARE HOLDINGS CORPORATION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invacare Holdings Corporation (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Shulamit Leviant, Esq. c/o Davidson Kempner Capital Management |
|
| February 15, 2024 |
US461203AH42 / Invacare Corp Bond / SILVERBACK ASSET MANAGEMENT LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Elliot Bossen Silverback Asset Management, LLC 1414 Raleigh Road Chapel Hill, NC 27517 (919) 969-9300 |
|
| February 12, 2024 |
IVC / Invacare Corp. / FIRST MANHATTAN CO Passive Investment SC 13G/A 1 firstmanhattan-ivcrq123123a1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* INVACARE CORPORATION (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 461203101 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the |
|
| February 9, 2024 |
SC 13G/A 1 ivca120824.htm CHARLES SCHWAB INVESTMENT MANAGEMENT INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invacare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 461203101 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check |
|
| February 2, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Invacare Holdings Corporation (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Shulamit Leviant, Esq. c/o Davidson Kempner Capital Management LP 520 Madison Avenue, 30th Floor New York, New York 10022 (21 |
|
| February 2, 2024 |
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) EX-99 2 exhibit991.htm JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) EXHIBIT 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the nece |
|
| February 2, 2024 |
SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Robin Shah Tenor Capital Management Company, L.P. 810 Seventh Avenue, Suite 1905 New York, NY 10019 ( |
|
| February 2, 2024 |
US461203AH42 / Invacare Corp Bond / SILVERBACK ASSET MANAGEMENT LLC - SC 13D/A Activist Investment SC 13D/A 1 d699831dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Elliot Bossen Silverback Asset Management, LLC 1414 Raleigh Road Chapel |
|
| February 2, 2024 |
US461203AH42 / Invacare Corp Bond / DG Capital Management, LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Dov Gertzulin DG Capital Management, LLC 460 Park Avenue, 22nd Floor New York, NY 10022 (646) 942-570 |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report |
|
| September 19, 2023 |
IVC / Invacare Corp. / Rosen Steven H - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Steven H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 350 Cleveland, OH 44122 (216) 2 |
|
| September 19, 2023 |
INVACARE HOLDINGS CORPORATION WARRANT AGREEMENT EX-99.4 2 d496261dex994.htm EXHIBIT 4 Exhibit 4 EXECUTION COPY INVACARE HOLDINGS CORPORATION WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”) is dated this September 15, 2023 by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and Azurite Management LLC, an Ohio limited liability company (the “Warrant Holder”). W I T N E S S E T H WHEREAS, in exchange f |
|
| September 14, 2023 |
IVC / Invacare Corp. / SILVERBACK ASSET MANAGEMENT LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Elliot Bossen Silverback Asset Management, LLC 1414 Raleigh Road Chapel Hill, NC 27517 (919) 969-9300 |
|
| September 13, 2023 |
Exhibit 16.1 September 13, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read Item 4.01(a) of Form 8-K dated September 13, 2023, of Invacare Holdings Corporation and are in agreement with the statements contained in the second, third, and fourth paragraphs on page 2 therein. We have no basis to agree or disagree with other statements of the |
|
| September 13, 2023 |
IVC / Invacare Corp. / TENOR CAPITAL MANAGEMENT Co., L.P. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Robin Shah Tenor Capital Management Company, L.P. 810 Seventh Avenue, Suite 1905 New York, NY 10019 ( |
|
| September 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2023 (September 7, 2023) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction |
|
| September 11, 2023 |
EX-99.1 2 d552297dex991.htm EX-99.1 Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned acknowledges and agrees that the foregoing statement on this Schedule 13D is filed on behalf of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of th |
|
| September 11, 2023 |
IVC / Invacare Corp. / DG Capital Management, LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Dov Gertzulin DG Capital Management, LLC 460 Park Avenue, 22nd Floor New York, NY 10022 (646) 942-570 |
|
| September 8, 2023 |
EX-99.1 2 d846491dex991.htm EX-99.1 Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned acknowledges and agrees that the foregoing statement on this Schedule 13D is filed on behalf of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of th |
|
| September 8, 2023 |
IVC / Invacare Corp. / Endurant Capital Management LP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Quang Minh Pham Endurant Capital Management, LP 66 Bovet Road, Suite 353 San Mateo, CA 94402 (650) 5 |
|
| September 7, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2023 (September 2, 2023) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction o |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Fo |
|
| June 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 (June 22, 2023) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of incorp |
|
| June 26, 2023 |
Exhibit 10.1 PERSONAL AND CONFIDENTIAL June 23, 2023 Mr. Kai Zhu Address Redacted Dear Kai: I am pleased to offer you the position of Senior Vice President and Chief Financial Officer (“CFO”) of Invacare Holdings Corporation (the “Company” or “Invacare”), reporting directly to the President and Chief Executive Officer of Invacare (“CEO”). The effective date of your appointment under this letter ag |
|
| June 26, 2023 |
INVACARE HOLDINGS CORPORATION NAMES KAI ZHU SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] INVACARE HOLDINGS CORPORATION NAMES KAI ZHU SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER ELYRIA, Ohio (June 26, 2023) – Invacare Holdings Corporation (“Invacare” or “the company”), announced today that it has appointed Kai Zhu as Senior Vice President and Chief Financial Officer, effective July 1, 2023. Mr. Zhu, 46, has served as In |
|
| June 26, 2023 |
CHANGE OF CONTROL SEVERANCE AGREEMENT Exhibit 10.2 CHANGE OF CONTROL SEVERANCE AGREEMENT THIS CHANGE OF CONTROL SEVERANCE AGREEMENT (“Agreement”), is made as of the 23rd day of June, 2023 (the “Effective Date”), by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“Invacare”) and KAI ZHU (the “Executive”). WHEREAS, in recognition of the importance of the Executive’s services to the continuity of management and success o |
|
| June 6, 2023 |
As filed with the Securities and Exchange Commission on June 6, 2023 Registration No. |
|
| June 6, 2023 |
Exhibit 107 Form S-8 (Form Type) Invacare Holdings Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price(3) Fee Rate Amount of Registration Fee Equity Common Stock, par value $0. |
|
| May 26, 2023 |
Invacare Holdings Corporation Conflict Minerals Report For The Year Ended December 31, 2022 Exhibit 1.01 Invacare Holdings Corporation Conflict Minerals Report For The Year Ended December 31, 2022 This report for the year ended December 31, 2022 is provided pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended (the “Rule”). This report has been prepared by Invacare Holdings Corporation (herein referred to as “Invacare,” the “Company,” “we,” “us,” or “ou |
|
| May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INVACARE HOLDINGS CORPORATION (Exact name of Registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Invacare Way, Elyria, Ohio 44035 (Address of principal exec |
|
| May 24, 2023 |
EX-1 EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13D. |
|
| May 24, 2023 |
IVC / Invacare Corp. / Rosen Steven H - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Stephen H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 350 Cleveland, OH 44122 (216) |
|
| May 17, 2023 |
15-12G 1 invacare-form15kedraft5102.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-15103 Invacare Corporatio |
|
| May 15, 2023 |
EX-99.4 Exhibit 4 Board Observer Agreement This agreement (the “Agreement”) is made effective as of May 5, 2023 by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and Endurant Capital Management LP (the “Investor”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the bylaws of the Company, as amended from time to ti |
|
| May 15, 2023 |
EX-99.1 Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned acknowledges and agrees that the foregoing statement on this Schedule 13D is filed on behalf of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of the undersigned without the ne |
|
| May 15, 2023 |
IVC / Invacare Corp. / DG Capital Management, LLC - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Dov Gertzulin DG Capital Management, LLC 460 Park Avenue, 22nd Floor New York, NY 10022 (646) 942-5700 ( |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [☒] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR [☐] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-15103 INVACARE HOLDINGS |
|
| May 15, 2023 |
Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE REPORTS RESULTS FOR FIRST QUARTER 2023 Improved operating results driven by lower SG&A expense and expanded gross margin ELYRIA, Ohio - (May 15, 2023) - Invacare Holdings Corporation (OTC: IVCRQ) (“Invacare” or the “company”) today reported results of its predecessor Invacare Corporation for the quarter ended March |
|
| May 15, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 15, 2023 INVACARE HOLDINGS CORPORATION (Exact name of Registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other Jurisdiction of Incorporation or Organi |
|
| May 15, 2023 |
IVC / Invacare Corp. / Endurant Capital Management LP - SC 13D Activist Investment SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Quang Minh Pham Endurant Capital Management, LP 66 Bovet Road, Suite 353 San Mateo, CA 94402 (650) 539-5 |
|
| May 15, 2023 |
EX-99.4 Exhibit 4 Board Observer Agreement This agreement (the “Agreement”) is made effective as of May 5, 2023 by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and DG Capital Management, LLC (the “Investor”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the bylaws of the Company, as amended from time to time ( |
|
| May 15, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 46124A101 (CUSIP Number) May 5, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| May 15, 2023 |
Exhibit 4 Board Observer Agreement This agreement (the “Agreement”) is made effective as of May 5, 2023 by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and Silverback Asset Management, LLC (the “Investor”). |
|
| May 15, 2023 |
IVC / Invacare Corp. / TENOR CAPITAL MANAGEMENT Co., L.P. - SC 13D Activist Investment SC 13D 1 d461360dsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Robin Shah Tenor Capital Management Company, L.P. 810 Seventh Avenue, Suite 1 |
|
| May 15, 2023 |
IVC / Invacare Corp. / SILVERBACK ASSET MANAGEMENT LLC - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Invacare Holdings Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46124A101 (CUSIP Number) Elliot Bossen Silverback Asset Management, LLC 1414 Raleigh Road Chapel Hill, NC 27517 (919) 969-9300 (Name, Ad |
|
| May 15, 2023 |
EX-99.4 Exhibit 4 Board Observer Agreement This agreement (the “Agreement”) is made effective as of May 5, 2023 by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and Tenor Capital Management company, L.P. (the “Investor”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the bylaws of the Company, as amended from ti |
|
| May 15, 2023 |
EX-99.1 Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned acknowledges and agrees that the foregoing statement on this Schedule 13D is filed on behalf of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of the undersigned without the ne |
|
| May 15, 2023 |
EX-99.1 Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned acknowledges and agrees that the foregoing statement on this Schedule 13D is filed on behalf of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of the undersigned without the ne |
|
| May 15, 2023 |
Joint Filing Statement Statement Pursuant to Rule 13d-1(k)(1) EX-99.1 Exhibit 1 Joint Filing Statement Statement Pursuant to Rule 13d-1(k)(1) The undersigned hereby consent and agree to file a joint statement on Schedule 13D under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, par value $0.001 per share, of Invacare Holdings Corporation, beneficially owned by them, together with any or all amendments thereto, when and if a |
|
| May 8, 2023 |
Exhibit 4.4 INVACARE HOLDINGS CORPORATION AND THE NOTES GUARANTORS LISTED ON THE SIGNATURE PAGES HERETO AND GLAS TRUST COMPANY LLC, as Trustee and Notes Collateral Agent INDENTURE Dated as of May 5, 2023 7.50% Convertible Senior Secured Notes due 2028, Tranche II #96856656v2 TABLE OF CONTENTS Page ARTICLE 1 Definitions 7 Section 1.01. Definitions 7 Section 1.02. References to Interest 35 Section 1 |
|
| May 8, 2023 |
Non-Employee Director Compensation Effective May 2023 Exhibit 10.5 Non-Employee Director Compensation Effective May 2023 Board Members: Annual Retainer: $ 65,000 Annual Equity Award: $ 115,000 (1)(2) $ 180,000 Non-Executive Chairman Fee: Annual Retainer $ 85,000 Annual Equity Award $ 150,000 (1) (2) Warrants for 2% of the Common Stock, exercisable at an Enterprise Value of $285M, vesting ratably over 3 years or at an Enterprise Value of $400M Lead In |
|
| May 8, 2023 |
Exhibit 10.7 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 5, 2023, and will be effective as of the effective date of Invacare Corporation’s Chapter 11 Plan (the “Effective Date”), by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”) and Kathleen P. Leneghan (the “Executive”). Capitalized terms used but not otherwise def |
|
| May 8, 2023 |
Exhibit 4.1 INVACARE HOLDINGS CORPORATION AND THE NOTES GUARANTORS LISTED ON THE SIGNATURE PAGES HERETO AND GLAS TRUST COMPANY LLC, as Trustee and Notes Collateral Agent INDENTURE Dated as of May 5, 2023 7.50% Convertible Senior Secured Notes due 2028, Tranche I #96856647v2 TABLE OF CONTENTS Page ARTICLE 1 Definitions 7 Section 1.01. Definitions 7 Section 1.02. References to Interest 35 Section 1. |
|
| May 8, 2023 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION INVACARE HOLDINGS CORPORATION Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INVACARE HOLDINGS CORPORATION Invacare Holdings Corporation (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), hereby certifies as follows: 1. The original Certificate of Incorporation of the Corporation the (the “Original Certificate of Incorporation”) w |
|
| May 8, 2023 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF INVACARE HOLDINGS CORPORATION (Adopted as of May 5, 2023) ARTICLE I OFFICES Section 1.1 Registered Office; Registered Agent. The address of the initial registered office of Invacare Holdings Corporation (the “Corporation”) in the State of Delaware is c/o Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle, Delawar |
|
| May 8, 2023 |
Exhibit 3.3 CERTIFICATE OF DESIGNATIONS OF 9.00% SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK OF INVACARE HOLDINGS CORPORATION Section 1 Designation and Number of Shares. Pursuant to the Charter, there is hereby created out of the authorized and unissued shares of preferred stock of the Corporation, par value $0.001 per share (“Preferred Stock”), a series of Preferred Stock consisting of 6,7 |
|
| May 8, 2023 |
Exhibit 4.7 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made as of May 5, 2023 by and among Invacare Holdings Corporation, a Delaware corporation (the “Company”), and the other parties signatory hereto and any additional parties identified on the signature pages of any joinder agreement executed and delivered pursuant hereto. Certain definitions are set f |
|
| May 8, 2023 |
Exhibit 10.3 INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of [], 2023 by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”), and the individual identified as the Indemnitee on the signature page hereto (“Indemnitee”). RECITALS: WHEREAS, directors, officers and other persons in service to corporations or business enterprises are su |
|
| May 8, 2023 |
Exhibit 10.6 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 5, 2023, and will be effective as of the effective date of Invacare Corporation’s Chapter 11 Plan (the “Effective Date”), by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”) and Geoffrey P. Purtill (the “Executive”). Capitalized terms used but not otherwise defi |
|
| May 8, 2023 |
INVACARE HOLDINGS CORPORATION 2023 MANAGEMENT INCENTIVE PLAN Exhibit 10.4 INVACARE HOLDINGS CORPORATION 2023 MANAGEMENT INCENTIVE PLAN 1. Purpose; Effective Date. a. Purpose. The purpose of the 2023 Invacare Holdings Corporation Management Incentive Plan (the “Plan”) is to align the interests of Employees with those of the stockholders of Invacare Holdings Corporation (the “Company”) by providing such individuals with long-term incentive compensation opport |
|
| May 8, 2023 |
Exhibit 10.2 LOAN AND SECURITY AGREEMENT dated as of May 5, 2023 among INVACARE HOLDINGS CORPORATION, as Parent, INVACARE CORPORATION, FREEDOM DESIGNS, INC., MEDBLOC, INC., INVACARE CANADA L.P., MOTION CONCEPTS L.P., PERPETUAL MOTION ENTERPRISES LIMITED, as Borrowers, THE SUBSIDIARIES OF PARENT PARTY HERETO, as Guarantors, THE ENTITIES FROM TIME TO TIME PARTY HERETO, as Lenders, and WHITE OAK COMM |
|
| May 8, 2023 |
Exhibit 99.1 Invacare Holdings Corporation Completes Financial Restructuring and is Well Positioned to Drive Forward in its Transformation Successfully Recapitalized Debt and Equity Structure Reorganized Company Appoints New Board of Directors and Existing Management Team Continues to Lead the Global Business ELYRIA, Ohio— May 8, 2023 – Invacare Holdings Corporation (“Invacare” or “the company”), |
|
| May 8, 2023 |
AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENT Exhibit 10.9 AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENT This AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENT (“Agreement”), is made as of the 5TH day of May, 2023, and will be effective as of the effective date of Invacare Corporation’s Chapter 11 Plan (the “Effective Date”), by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“New Holdings”), INVACARE CO |
|
| May 8, 2023 |
Exhibit 10.1 AMENDED AND RESTATED CREDIT AGREEMENT dated as of May 5, 2023 among INVACARE HOLDINGS CORPORATION, as Holdings, INVACARE CORPORATION, as the Borrower, The LENDERS Party Hereto, CANTOR FITZGERALD SECURITIES, as Administrative Agent, and GLAS TRUST COMPANY LLC, as Collateral Agent TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 Section 1.01 Defined Terms 2 Section 1.02 Classification of |
|
| May 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K12G3 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 (May 5, 2023) INVACARE HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-15103 38-4264819 (State or other jurisdiction of incorp |
|
| May 8, 2023 |
AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENT Exhibit 10.10 AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENT This AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENT (“Agreement”), is made as of the 5TH day of May, 2023, and will be effective as of the effective date of Invacare Corporation’s Chapter 11 Plan (the “Effective Date”), by and among INVACARE HOLDINGS CORPORATION, a Delaware corporation (“New Holdings”), INVACARE C |
|
| May 8, 2023 |
Exhibit 10.8 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 5, 2023, and will be effective as of the effective date of Invacare Corporation’s Chapter 11 Plan (the “Effective Date”), by and between Invacare Holdings Corporation, a Delaware corporation (the “Company”) and Anthony LaPlaca (the “Executive”). Capitalized terms used but not otherwise defined |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 5, 2023 |
As filed with the Securities and Exchange Commission on May 5, 2023 As filed with the Securities and Exchange Commission on May 5, 2023 Registration Statement No. |
|
| May 2, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits, Bankruptcy or Receivership UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 (April 28, 2023) INVACARE CORPORATION (Exact name of registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other jurisdiction of incorporation) (Comm |
|
| May 2, 2023 |
a2023-04x28orderconfirmi 31969455.3 IN THE UNITED STATES BANKRUPTCY COURT FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION ) In re: ) Chapter 11 ) INVACARE CORPORATION, et al.,1 ) Case No. 23-90068 (CML) ) Debtors. ) (Jointly Administered) ) ORDER CONFIRMING THE DEBTORS’ FIRST AMENDED JOINT CHAPTER 11 PLAN OF INVACARE CORPORATION AND ITS DEBTOR AFFILIATES (TECHNICAL MODIFICATIONS) The above-cap |
|
| April 14, 2023 |
INVACARE CORPORATION AGREEMENT This AGREEMENT (“Agreement”), is made as of the [*] day of [month, year], between INVACARE CORPORATION, an Ohio corporation (“Invacare”), and (the Executive”). |
|
| April 14, 2023 |
Non-Employee Director Compensation Effective December 2022 Non-Employee Director Compensation Effective December 2022 Board Members: Annual Retainer: $ 105,000 Annual Equity Award: $ 90,000 (1)(2) $ 195,000 Non-Executive Chairman Fee: $ 40,000 Committee Chair Fees: Audit $ 15,000 Compensation $ 15,000 Nominating & Governance $ 10,000 Regulatory & Compliance $ 15,000 Special $ 20,000 Meeting Fees: $ 1,500 (3) Notes: (1)Target Value of restricted stock units (2)New Directors receive an award of a pro-rated number of shares of the most recent annual grant based on the months remaining until the next annual grant (3)For meetings attended in excess of 24 in a year Rev. |
|
| April 14, 2023 |
INVACARE CORPORATION FORM OF INDEMNITY AGREEMENT INVACARE CORPORATION FORM OF INDEMNITY AGREEMENT THIS AGREEMENT is made as of the day of , 20, by and between INVACARE CORPORATION, an Ohio corporation (the “Corporation”), and (“Indemnitee”), an Officer and/or Director of the Corporation. |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————————————— FORM 10-K ————————————————————— ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file |
|
| April 14, 2023 |
PERSONAL AND CONFIDENTIAL November 21, 2022 Mr. Geoffrey P. Purtill Neumattstrasse 10 Reinach BL 4153 Switzerland Dear Geoff: On behalf of the Board of Directors (the “Board”) of Invacare Corporation (“Invacare” or “Company”), I am pleased to confirm your appointment by the Board to the position of President and Chief Executive Officer (“CEO”), reporting directly to the Board. The effective date o |
|
| April 14, 2023 |
SEPARATION AGREEMENT This Separation Agreement (hereinafter “Agreement”) is made by and between INVACARE CORPORATION (hereinafter “Company”) and RICK A. |
|
| April 14, 2023 |
PERSONAL AND CONFIDENTIAL January 3, 2023 Cintia Ferreira Hölzlistrasse 57 A 4102 Binningen Switzerland Dear Cintia: I am pleased to confirm your appointment to the position of Chief Human Resources Officer (“CHRO”) of Invacare Corporation (the “Company” or “Invacare”), reporting directly to me. |
|
| April 14, 2023 |
Cintia Ferreira Im Hügliacker 2b 4102 Binningen Switzerland Witterswil, September 16th 2020 Dear Cintia, Following our discussions we have the pleasure in confirming your employment contract with our Company at the following terms and conditions: Between Invacare International GmbH (in the following referred to as the “Company”) And Cintia Ferreira (in the following referred to as the “Employee”) 1. |
|
| April 14, 2023 |
Exhibit 21 Invacare Corporation Subsidiaries 1 Adaptive Switch Laboratories, Inc., a Texas corporation. 2 Alber GmbH, a German limited liability company. 3 Alber GmbH, a Swiss limited liability company. 4 Invacare Logistics GmbH, a German limited liability company. 5 Carroll Healthcare General Partner Inc., an Ontario corporation. 6 Carroll Healthcare Inc., an Ontario corporation. 7 Freedom Design |
|
| April 14, 2023 |
FIRST AMENDED AND RESTATED BACKSTOP COMMITMENT AGREEMENT AMONG INVACARE CORPORATION EACH OF THE COMPANY PARTIES LISTED ON SCHEDULE 1 HERETO AND THE BACKSTOP PARTIES PARTY HERETO DATED AS OF MARCH 29, 2023 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 Section 1. |
|
| April 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2023 (April 5, 2023) INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or O |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2023 (March 29, 2023) INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or O |
|
| April 3, 2023 |
a357732015xinvacare-dis 31298697.2 IN THE UNITED STATES BANKRUPTCY COURT FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION ) In re: ) Chapter 11 ) INVACARE CORPORATION, et al.,1 ) Case No. 23-90068 (CML) ) Debtors. ) (Jointly Administered) ) FIRST AMENDED DISCLOSURE STATEMENT FOR THE FIRST AMENDED JOINT CHAPTER 11 PLAN OF INVACARE CORPORATION AND ITS DEBTOR AFFILIATES 1 The Debtors in these Chap |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o |
|
| February 16, 2023 |
EX-99.25 2 ruleprovisionnotice.htm NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange ('NYSE' or the 'Exchange') hereby notifies the Securities and Exchange Commission (the 'Commission') of its intention to remove the Common Shares, (the "Common Shares") of Invacare Corporation (the "Company") from listing and registration on the Exchange |
|
| February 14, 2023 |
IVC / Invacare Corporation / FIRST MANHATTAN CO Passive Investment SC 13G 1 firstmanhattan-ivcrq123122.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* INVACARE CORPORATION (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 461203101 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the approp |
|
| February 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Invacare Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 461203101 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X |
|
| February 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2023 (February 1, 2023) INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation |
|
| February 3, 2023 |
Exhibit 10.1 SUPERPRIORITY SECURED DEBTOR-IN-POSSESSION CREDIT AGREEMENT dated as of February 2, 2023 among INVACARE CORPORATION, a debtor and debtor-in-possession under Chapter 11 of the Bankruptcy Code, as the Borrower, The LENDERS Party Hereto, CANTOR FITZGERALD SECURITIES, as Administrative Agent, and GLAS TRUST CORPORATION LIMITED, as Collateral Agent TABLE OF CONTENTS Page ARTICLE 1 DEFINITI |
|
| February 3, 2023 |
Exhibit 10.2 DEBTOR-IN-POSSESSION REVOLVING CREDIT AND SECURITY AGREEMENT PNC BANK, NATIONAL ASSOCIATION, as a Lender and Agent, and THE OTHER LENDERS PARTY HERETO WITH INVACARE CORPORATION, as a Borrower, THE OTHER BORROWERS PARTY HERETO THE GUARANTORS PARTY HERETO February 2, 2023 TABLE OF CONTENTS Page 1. DEFINITIONS. 2 1.1 Accounting Terms 2 1.2 General Terms 2 1.3 Uniform Commercial Code Term |
|
| February 1, 2023 |
EX-2.1 2 ex21assetpurchaseagreement.htm EX-2.1 Exhibit 2.1 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (this “Agreement”), dated as of January 30, 2023, is entered into by and between Invacare Corporation, an Ohio corporation (“Invacare”) and Ventec Life Systems, Inc., a Delaware corporation (“Buyer”). Invacare and Buyer shall be referred to herein individually as a “Party” and collecti |
|
| February 1, 2023 |
Discussion Materials 2 Forward Looking Statements This presentation contains highly confidential information and is solely for informational purposes. |
|
| February 1, 2023 |
EX-10.2 4 a102invacare-backstopagre.htm EX-10.2 Exhibit 10.2 BACKSTOP COMMITMENT AGREEMENT AMONG INVACARE CORPORATION EACH OF THE COMPANY PARTIES LISTED ON SCHEDULE 1 HERETO AND THE BACKSTOP PARTIES PARTY HERETO DATED AS OF JANUARY 31, 2023 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 2 Section 1.1 Definitions 2 Section 1.2 Construction 15 ARTICLE II BACKSTOP COMMITMENT 16 Section 2.1 The Rights O |
|
| February 1, 2023 |
Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE CORPORATION TAKES ACTION TO STRENGTHEN ITS FINANCIAL POSITION AND DRIVE LONG-TERM GROWTH THROUGH VOLUNTARY PREARRANGED CHAPTER 11 CASES THAT DO NOT INCLUDE ITS INTERNATIONAL OPERATIONS Refinancing action will reduce net debt by approximately 65% Global manufacturing and delivery of products to continue uninterrupted |
|
| February 1, 2023 |
RESTRUCTURING SUPPORT AGREEMENT Exhibit 10.1 THIS RESTRUCTURING SUPPORT AGREEMENT IS NOT AN OFFER OR ACCEPTANCE WITH RESPECT TO ANY SECURITIES OR A SOLICITATION OF ACCEPTANCES OF A CHAPTER 11 PLAN WITHIN THE MEANING OF SECTION 1125 OF THE BANKRUPTCY CODE. ANY SUCH OFFER OR SOLICITATION WILL COMPLY WITH ALL APPLICABLE SECURITIES LAWS AND/OR PROVISIONS OF THE BANKRUPTCY CODE. NOTHING CONTAINED IN THIS RESTRUCTURING SUPPORT AGREEME |
|
| February 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2023 (January 27, 2023) INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation |
|
| January 31, 2023 |
[REMAINDER OF PAGE LEFT INTENTIONALLY BLANK] EX-10.1 6 a101retentionagreementswi.htm EX-10.1 Exhibit 10.1 Personal and Confidential January [Date], 2023 [Full Name] [Email Address] Re: Retention Bonus Dear [First Name]: On behalf of the Board of Directors (the “Board”) of Invacare Corporation, an Ohio corporation (the “Company”) and Invacare International GmbH (“IIG”), I am pleased to offer you the opportunity to receive a cash retention bon |
|
| January 31, 2023 |
[REMAINDER OF PAGE LEFT INTENTIONALLY BLANK] EX-10.2 7 a102retentionagreementusf.htm EX-10.2 Exhibit 10.2 Personal and Confidential January [Date], 2023 [Full Name] [Email Address] Re: Retention Bonus Dear [First Name]: On behalf of the Board of Directors (the “Board”) of Invacare Corporation, an Ohio corporation (the “Company”), I am pleased to offer you the opportunity to receive a cash retention bonus in the amount of USD $ (the “Retentio |
|
| January 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2023 (January 25, 2023) INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation |
|
| December 27, 2022 |
[Remainder of Page Intentionally Left Blank] EX-10.1 2 exhibit101amendmentno2toc.htm EX-10.1 Exhibit 10.1 AMENDMENT AGREEMENT, dated as of December 23, 2022 (this “Amendment”), in respect of the Credit Agreement (as defined below) among Invacare Corporation, an Ohio corporation (the “Borrower”), the Lenders party hereto (such Lenders, including all of the Lenders holding Third Additional Term Loan Commitments and all Lenders holding outstand |
|
| December 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2022 (December 23, 2022) INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporati |
|
| December 27, 2022 |
INVACARE CORPORATION ANNOUNCES ADDITIONAL DRAW OF TERM LOANS EX-99.1 3 exhibit9912022-12x27xhbxf.htm EX-99.1 Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE CORPORATION ANNOUNCES ADDITIONAL DRAW OF TERM LOANS ELYRIA, OH (December 27, 2022) - Invacare Corporation (NYSE:IVC) (“Invacare” or the “company”) announced the consummation of an additional draw of $5,500,000 of term loans under to its Credit Agreement with certain fu |
|
| December 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) ( |
|
| December 9, 2022 |
SEPARATION AGREEMENT AND GENERAL RELEASE Exhibit 10.1 SEPARATION AGREEMENT AND GENERAL RELEASE THIS SEPARATION AGREEMENT AND GENERAL RELEASE (“Agreement”) is made and entered into by and between Invacare Corporation, an Ohio corporation (the "Company") and Matthew E. Monaghan ("Executive"), with an Effective Date as defined herein. W I T N E S S E T H: WHEREAS, pursuant to an Employment Agreement between the Company and Executive dated M |
|
| November 22, 2022 |
Exhibit 7.8 Invacare Corporation One Invacare Way Elyria, OH 44035 Attn.: Anthony LaPlaca, Senior Vice President, General Counsel, Chief Administrative Officer & Secretary November 21, 2022 Dear Anthony, I hereby agree and consent, for all purposes under the Invacare Corporation 2018 Equity Compensation Plan, as amended, and the applicable award agreement, to the immediate forfeiture and terminati |
|
| November 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization |
|
| November 22, 2022 |
AMENDMENT NO. 1 TO COOPERATION AGREEMENT EX-7.6 Exhibit 7.6 AMENDMENT NO. 1 TO COOPERATION AGREEMENT This Amendment No. 1 to the Cooperation Agreement (this “Amendment”), dated as of November 21, 2022, is by and among Azurite Management LLC, an Ohio limited liability company (together with the members of its investment “group” for purposes of Schedule 13D filed with the SEC executing this Agreement on the signature pages hereto, “Azurite |
|
| November 22, 2022 |
IVC / Invacare Corporation / Rosen Steven H - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Invacare Corporation (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 461203101 (CUSIP Number) Steven H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 350 Cleveland, OH 44122 (216) 292-4535 with copi |
|
| November 22, 2022 |
AMENDMENT NO. 1 TO COOPERATION AGREEMENT Exhibit 10.1 AMENDMENT NO. 1 TO COOPERATION AGREEMENT This Amendment No. 1 to the Cooperation Agreement (this “Amendment”), dated as of November 21, 2022, is by and among Azurite Management LLC, an Ohio limited liability company (together with the members of its investment “group” for purposes of Schedule 13D filed with the SEC executing this Agreement on the signature pages hereto, “Azurite”), an |
|
| November 22, 2022 |
Exhibit 7.7 Invacare Corporation One Invacare Way Elyria, OH 44035 Attn.: Anthony LaPlaca, Senior Vice President, General Counsel, Chief Administrative Officer & Secretary November 21, 2022 Dear Anthony, I hereby agree and consent, for all purposes under the Invacare Corporation 2018 Equity Compensation Plan, as amended, and the applicable award agreement, to the immediate forfeiture and terminati |
|
| November 21, 2022 |
Invacare Appoints Geoff Purtill President and Chief Executive Officer Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 Invacare Appoints Geoff Purtill President and Chief Executive Officer ELYRIA, Ohio (November 21, 2022) - Invacare Corporation (NYSE: IVC) announced today that its Board of Directors has named Geoffrey P. Purtill as President and Chief Executive Officer, roles that he has served on an interim basis since August 28, 2022. Non- |
|
| November 21, 2022 |
AMENDMENT NO. 1 TO COOPERATION AGREEMENT Exhibit 10.1 AMENDMENT NO. 1 TO COOPERATION AGREEMENT This Amendment No. 1 to the Cooperation Agreement (this ?Amendment?), dated as of November 21, 2022, is by and among Azurite Management LLC, an Ohio limited liability company (together with the members of its investment ?group? for purposes of Schedule 13D filed with the SEC executing this Agreement on the signature pages hereto, ?Azurite?), an |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) |
|
| November 21, 2022 |
Exhibit 10.2 PERSONAL AND CONFIDENTIAL November 21, 2022 Mr. Geoffrey P. Purtill Neumattstrasse 10 Reinach BL 4153 Switzerland Dear Geoff: On behalf of the Board of Directors (the ?Board?) of Invacare Corporation (?Invacare? or ?Company?), I am pleased to confirm your appointment by the Board to the position of President and Chief Executive Officer (?CEO?), reporting directly to the Board. The eff |
|
| November 7, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) ( |
|
| November 7, 2022 |
Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE REPORTS RESULTS FOR THIRD QUARTER 2022 Updates strategic priorities with the discontinuation of the production of respiratory products Anticipates sequential improvement in revenues and profitability in 4Q22 ELYRIA, Ohio - (November 7, 2022) - Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today repo |
|
| November 7, 2022 |
CONFIDENTIAL, WITHOUT PREJUDICE & NOT TO BE USED IN COURT AMENDMENT TO TERMINATION AGREEMENT CONFIDENTIAL, WITHOUT PREJUDICE & NOT TO BE USED IN COURT AMENDMENT TO TERMINATION AGREEMENT between Invacare International GmbH, Benkenstrasse 260, 4108 Witterswil, Switzerland (the "Company") and Ralf Ledda, Helsinkistrasse 7, 4142 M?nchenstein, Switzerland (the "Employee") (each individually a "Party" and collectively the "Parties") Preamble The Parties entered into a Termination Agreement dated Feb 27/ March 1, 2022 (the "Termination Agreement") to amicably settle all aspects of the Employee?s employment and the termination thereof effective September 30, 2022. |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [☒] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR [☐] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-15103 INVACARE CORP |
|
| October 3, 2022 |
Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE CORPORATION ANNOUNCES ADDITIONAL DRAW OF TERM LOANS AND EXCHANGE OF EXISTING CONVERTIBLE NOTES ELYRIA, OH (October 3, 2022) - Invacare Corporation (NYSE:IVC) (?Invacare? or the ?company?) announced today the consummation of additional draws of an aggregate of $18,500,000 of term loans pursuant to its Credit Agreemen |
|
| October 3, 2022 |
Exhibit 4.6 FIRST SUPPLEMENTAL INDENTURE THIS FIRST SUPPLEMENTAL INDENTURE (this ?Supplemental Indenture?), dated as of October 3, 2022, among Invacare Corporation, an Ohio corporation, as issuer (the ?Company?), the Note Guarantors (as defined in the Indenture referred to herein), Computershare Trust Company, N.A., a national association, not in its individual capacity but solely as trustee under |
|
| October 3, 2022 |
[Remainder of Page Intentionally Left Blank] Exhibit 10.1 AMENDMENT AGREEMENT AND JOINDER TO FOREIGN GUARANTEE AGREEMENT, dated as of October 3, 2022 (this ?Amendment?), in respect of the Credit Agreement and Foreign Guarantee Agreement (each as defined below) among Invacare Corporation, an Ohio corporation (the ?Borrower?), the Foreign Loan Parties (together with the Borrower, the ?Loan Parties?), the Lenders party hereto (such Lenders, con |
|
| October 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (C |
|
| October 3, 2022 |
Exhibit 4.3 FIRST SUPPLEMENTAL INDENTURE THIS FIRST SUPPLEMENTAL INDENTURE (this ?Supplemental Indenture?), dated as of October 3, 2022, among Invacare Corporation, an Ohio corporation, as issuer (the ?Company?), the Note Guarantors (as defined in the Indenture referred to herein), Computershare Trust Company, N.A., a national association, not in its individual capacity but solely as trustee under |
|
| September 29, 2022 |
Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE CORPORATION RECEIVES NOTICE OF NONCOMPLIANCE WITH NYSE TRADING SHARE PRICE LISTING RULE Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard ELYRIA, Ohio (September 29, 2022) - Invacare Corporation (NYSE: IVC) today announced that it received notice from the New York Stock Exchange (the ?NY |
|
| September 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) |
|
| September 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) |
|
| September 15, 2022 |
INVACARE CORPORATION One Invacare Way, Elyria, Ohio 44035 USA 440-329-6000 www.invacare.com PERSONAL AND CONFIDENTIAL September 13, 2022 Mr. Geoffrey P. Purtill Neumattstrasse 10 Reinach BL 4153 Switzerland Dear Geoff: On behalf of the Board of Directors (the ?Board?) of Invacare Corporation (?Invacare? or ?Company?), I am pleased to confirm your appointment by the Board to the position of Interim President and Chief Executive Officer (?Interim CEO?), reporting directly to the Board. The |
|
| August 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (C |
|
| August 29, 2022 |
INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 Invacare Corporation Announces Executive Leadership Changes Appoints Geoff Purtill as Interim Chief Executive Officer and Michael Merriman as Board Chairman ELYRIA, Ohio (August 29, 2022) - Invacare Corporation (NYSE: IVC) today announced changes to its senior management team and Board of Directors to advance its previously announced bus |
|
| August 25, 2022 |
IVC / Invacare Corporation / Rosen Steven H - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Invacare Corporation (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 461203101 (CUSIP Number) Steven H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 350 Cleveland, OH 44122 (216) 292-4535 with copies to: Jo |
|
| August 25, 2022 |
Exhibit 7.3 LIMITED POWER OF ATTORNEY The undersigned hereby constitutes and appoints Brian E. Powers as the undersigned?s true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned?s capacity as a five-percent-owner or ten-percent-owner of Invacare Corporation (the ?Company?), from time to time the following U.S. Securities and Exchange Commission (? |
|
| August 25, 2022 |
Exhibit 7.2 LIMITED POWER OF ATTORNEY The undersigned hereby constitutes and appoints Brian E. Powers as the undersigned?s true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned?s capacity as a director, five-percent-owner or ten-percent-owner of Invacare Corporation (the ?Company?), from time to time the following U.S. Securities and Exchange Com |
|
| August 22, 2022 |
August 22, 2022 VIA EDGAR Securities and Exchange Commission Office of Life Sciences Division of Corporation Finance 100 F. |
|
| August 22, 2022 |
COOPERATION AGREEMENT This Cooperation Agreement (this ?Agreement?), dated as of August 22, 2022, is by and among Azurite Management LLC, an Ohio limited liability company (together, with the members of its investment ?group? for purposes of Schedule 13D filed with the SEC executing this Agreement on the signature pages hereto, ?Azurite?), and Invacare Corporation, an Ohio corporation (?Invacare? or the ?Company?), with respect to the matters set forth below. |
|
| August 22, 2022 |
INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE CORPORATION ANNOUNCES COOPERATION AGREEMENT WITH AZURITE MANAGEMENT Adds two independent directors with business transformation expertise ELYRIA, Ohio (August 22, 2022) - Invacare Corporation (NYSE: IVC) today announced that it has entered into a cooperation agreement with its largest shareholder, Azurite Management LLC (?Azurit |
|
| August 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (C |
|
| August 16, 2022 |
As filed with the Securities and Exchange Commission on August 16, 2022 Registration No. |
|
| August 16, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Invacare Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Title of Securities to be Registered Fee Calculation Rule Amount Registered (1)(2) Proposed Maximum Offering Price Per Share(3) Proposed Maximum Aggregate Offering Price(3) Fee Rate Amount of Registration Fee Equity Common Shares, without par value 457(c) 32,402,336 $1. |
|
| August 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (Co |
|
| August 8, 2022 |
Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE REPORTS RESULTS FOR SECOND QUARTER 2022 Achieved sequential improvement in profitability and free cash flow ELYRIA, Ohio - (August 8, 2022) - Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended June 30, 2022. Executive Summary Reflecting on the quarter, Matt Mo |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [?] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR [?] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-15103 INVACARE CORPORATI |
|
| July 26, 2022 |
Exhibit 4.4 INVACARE CORPORATION AND THE NOTES GUARANTORS LISTED ON THE SIGNATURE PAGES HERETO AND COMPUTERSHARE TRUST COMPANY, N.A., as Trustee AND GLAS TRUST CORPORATION LIMITED, as Notes Collateral Agent INDENTURE Dated as of July 26, 2022 5.68% Convertible Senior Secured Notes due 2026, Tranche II TABLE OF CONTENTS Page ARTICLE 1 Definitions Section 1.01. Definitions. 5 Section 1.02. Reference |
|
| July 26, 2022 |
EX-4.1 2 a41indenturetranchei.htm EX-4.1 Exhibit 4.1 INVACARE CORPORATION AND THE NOTES GUARANTORS LISTED ON THE SIGNATURE PAGES HERETO AND COMPUTERSHARE TRUST COMPANY, N.A., as Trustee AND GLAS TRUST CORPORATION LIMITED, as Notes Collateral Agent INDENTURE Dated as of July 26, 2022 5.68% Convertible Senior Secured Notes due 2026, Tranche I TABLE OF CONTENTS Page ARTICLE 1 Definitions Section 1.01 |
|
| July 26, 2022 |
Exhibit 10.1 CREDIT AGREEMENT dated as of July 26, 2022 among INVACARE CORPORATION, as the Borrower, The LENDERS Party Hereto, CANTOR FITZGERALD SECURITIES, as Administrative Agent, and GLAS TRUST CORPORATION LIMITED, as Collateral Agent TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.01 Defined Terms 1 Section 1.02 Classification of Loans and Borrowings 56 Section 1.03 Terms Generally 56 |
|
| July 26, 2022 |
EX-10.2 6 a102secondamendedandresta.htm EX-10.2 Exhibit 10.2 CUSTOMER CUSIP 46122CAC3 NORTH AMERICAN FACILITY CUSIP 46122CAD1 SECOND AMENDED AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT PNC BANK, NATIONAL ASSOCIATION, as a Lender and Agent, and THE OTHER LENDERS PARTY HERETO WITH INVACARE CORPORATION, as a Borrower, THE OTHER BORROWERS PARTY HERETO THE GUARANTORS PARTY HERETO PNC CAPITAL M |
|
| July 26, 2022 |
Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE CORPORATION ANNOUNCES NEW SECURED CREDIT FACILITY OF UP TO $104.5 MILLION AND CONVERTIBLE DEBT EXCHANGE PROVIDES SECOND QUARTER BUSINESS UPDATE -The new Credit Facility provides an immediate and meaningful liquidity infusion, supporting working capital needs -Upon the satisfaction of certain post-closing conditions |
|
| July 26, 2022 |
RESALE REGISTRATION RIGHTS AGREEMENT Exhibit 4.7 RESALE REGISTRATION RIGHTS AGREEMENT THIS RESALE REGISTRATION RIGHTS AGREEMENT, dated as of July 26, 2022 (this ?Agreement?), has been entered into by and among Invacare Corporation, an Ohio corporation (the ?Company?), and the Noteholders (as defined below). BACKGROUND In connection with the Exchange Agreement, dated as of July 26, 2022 (the ?HB Tactical Exchange Agreement?), by and a |
|
| July 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (Com |
|
| June 7, 2022 |
IVC / Invacare Corporation / Rosen Steven H - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invacare Corporation (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 461203101 (CUSIP Number) Steven H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 350 Cleveland, OH 44122 (216) 292-4535 with copi |
|
| May 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Invacare Way, Elyria, Ohio 44035 (Address of principal executive offices |
|
| May 27, 2022 |
Invacare Corporation Conflict Minerals Report For The Year Ended December 31, 2021 EX-1.01 2 sd2021exhibit101.htm EX-1.01 Exhibit 1.01 Invacare Corporation Conflict Minerals Report For The Year Ended December 31, 2021 This report for the year ended December 31, 2021 is provided pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended (the “Rule”). This report has been prepared by Invacare Corporation (herein referred to as “Invacare,” the “Company |
|
| May 19, 2022 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (Comm |
|
| May 9, 2022 |
Exhibit 99.1 INVESTOR CONTACT: Lois Lee [email protected] 440-329-6435 INVACARE REPORTS RESULTS FOR FIRST QUARTER 2022 Delivered sales growth driven by mobility & seating and lifestyle products Reaffirmed full year 2022 financial guidance ELYRIA, Ohio - (May 9, 2022) - Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended March 31, 2022. Exe |
|
| May 9, 2022 |
Non-Employee Director Compensation Effective April 2022 Non-Employee Director Compensation Effective April 2022 Board Members: Annual Retainer: $ 105,000 Annual Equity Award: $ 90,000 (1)(2) $ 195,000 Lead Director Fee: $ 20,000 Committee Chair Fees: Audit $ 15,000 Compensation $ 15,000 Nominating & Governance $ 10,000 Regulatory & Compliance $ 15,000 Meeting Fees: $ 1,500 (3) Notes: (1)Target Value of restricted stock units (2)New Directors receive an award of a pro-rated number of shares of the most recent annual grant based on the months remaining until the next annual grant (3)For meetings attended in excess of 24 in a year Rev. |
|
| May 9, 2022 |
CONFIDENTIAL, WITHOUT PREJUDICE & NOT TO BE USED IN COURT TERMINATION AGREEMENT CONFIDENTIAL, WITHOUT PREJUDICE & NOT TO BE USED IN COURT TERMINATION AGREEMENT between Invacare International GmbH, Benkenstrasse 260, 4108 Witterswil, Switzerland (the "Company") and Ralf Ledda, Helsinkistrasse 7, 4142 M?nchenstein, Switzerland (the "Employee") (each individually a "Party" and collectively the "Parties") Preamble The Parties entered into an employment agreement dated October 21/23, 2016 (the "Employment Agreement"). |
|
| May 9, 2022 |
AWARD AGREEMENT (For Performance Unit Award) To: [Insert Name] Date of Grant: [Insert Date] There hereby is granted to you, as a key employee of Invacare Corporation (?Invacare?) or of a subsidiary, an award of Performance Units. |
|
| May 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [?] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR [?] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-15103 INVACARE CORPORAT |
|
| May 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 9, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (Commi |
|
| May 6, 2022 |
DEFA14A 1 defa14aupdatedirectorsdiv.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy St |
|
| May 4, 2022 |
Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (Commi |
|
| May 2, 2022 |
IVC / Invacare Corporation / Rosen Steven H - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Invacare Corporation (Name of Issuer) Common Shares, without par value (Title of Class of Securities) 461203101 (CUSIP Number) Steven H. Rosen Azurite Management LLC 25101 Chagrin Boulevard, Suite 350 Cleveland, OH 44122 (216) 292-4535 with copies to: Dan |
|
| May 2, 2022 |
Exhibit 7.3 LIMITED POWER OF ATTORNEY The undersigned hereby constitutes and appoints Brian E. Powers as the undersigned?s true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned?s capacity as director of Crawford United Corporation (the ?Company?), from time to time the following U.S. Securities and Exchange Commission (?SEC?) forms: (i) Schedules |
|
| May 2, 2022 |
EX-7.2 3 d717705dex72.htm EX-7.2 Exhibit 7.2 LIMITED POWER OF ATTORNEY The undersigned hereby constitutes and appoints Matthew V. Crawford as the undersigned’s true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned’s capacity as director of Crawford United Corporation (the “Company”), from time to time the following U.S. Securities and Exchange Co |
|
| May 2, 2022 |
EX-7.1 2 d717705dex71.htm EX-7.1 EXHIBIT 7.1 Joint Filing Agreement Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”), the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder |
|
| April 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soli |
|
| April 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soli |
|
| April 4, 2022 |
Invacare Corporation One Invacare Way, Elyria, OH 44035 USA 440-329-6000 www.invacare.com Exhibit 99.1 April 4, 2022 Dear Fellow Shareholders: 2021 was another challenging year as the world continued to grapple with the lingering impact of the COVID-19 pandemic. I am proud of the way Invacare team members rose to the occasion to provide an uninterrupted supply of our essential healthcare solutions for our customers and end-users. Through their hard work and dedication, we were able to |
|
| April 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soli |
|
| April 4, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2022 INVACARE CORPORATION (Exact name of Registrant as specified in its charter) Ohio 001-15103 95-2680965 (State or other Jurisdiction of Incorporation or Organization) (Com |
